DCLK1 and colorectal cancer: The main targets for CAR T cell therapy in colorectal cancer include CEA [206], MSLN [207], Guanylyl Cyclase C (GUCY2C) [208], EpCAM [209], HER2 [210], and Doublecortin-like kinase 1(DCLK1) [211].